Meta-analysis: Low-dose intake of vitamin e combined with other vitamins or minerals may decrease all-cause mortality

Journal of Nutritional Science and Vitaminology

Volumn 60, Issue 3, 2014, Pages 194-205

  Jiang, Shan ^a   Pan, Zhenyu ^b   Li, Hui ^c   Li, Fenglan ^c   Song, Yanyan ^a   Qiu, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XI AN CHILDREN S HOSPITAL   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

All cause mortality; Antioxidant; Meta analysis; Randomized controlled trial; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; TRACE ELEMENT; VITAMIN;

CARDIOVASCULAR DISEASES; DIET SUPPLEMENTATION; DOSE RESPONSE; FACTUAL DATABASE; HUMAN; META ANALYSIS; MORTALITY; NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MORTALITY; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRACE ELEMENTS; VITAMIN E; VITAMINS;

EID: 84905181725     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.60.194     Document Type: Article

References (67)

1. Prasad KN, Edwards-Prasad J. 1992. Vitamin E and cancer prevention: recent advances and future potentials. J Am Coll Nutr 11: 487-500.
2. Halliwell B. 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344: 721-724.
3. Witztum JL. 1994. The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795.
4. Upston JM, Terentis AC, Stocker R. 1999. Tocopherolmediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 13: 977-994.
5. Packer JE, Slater TF, Willson RL. 1979. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 278: 737-738.
6. Willson RL. 1987. Vitamin, selenium, zinc and copper interactions in free radical protection against ill-placed iron. Proc Nutr Soc 46: 27-34.
7. Bjorneboe A, Bjorneboe GE, Drevon CA. 1990. Absorption, transport and distribution of vitamin E. J Nutr 120: 233-242.
8. Verlangieri AJ, Bush MJ. 1992. Effects of d-alphatocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11: 131-138.
9. Meydani M. 1995. Vitamin E. Lancet 345: 170-175.
10. Steiner M. 1991. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 10: 466-473.
11. Niki E, Noguchi N, Tsuchihashi H, Gotoh N. 1995. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr 62: 1322S-1326S.
12. Machlin LJ, Gabriel E. 1980. Interactions of vitamin E with vitamin C, vitamin B12, and zinc. Ann NY Acad Sci 355: 98-108.
13. Ganther HE. 1980. Interactions of vitamin E and selenium with mercury and silver. Ann NY Acad Sci 355: 212-226.
14. Bettger WJ, Fish TJ, O'Dell BL. 1978. Effects of copper and zinc status of rats on erythrocyte stability and superoxide dismutase activity. Proc Soc Exp Biol Med 158: 279-282.
15. Tappel AL. 1968. Will antioxidant nutrients slow aging processes? Geriatrics 23: 97-105.
16. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. 2003. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361: 2017-2023.
17. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. 2004. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364: 1219-1228.
18. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. 2005. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46.
19. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, Suttorp MJ, Coulter I, Newberry SJ, Hardy M. 2004. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 19: 380-389.
20. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. 2012. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 3: CD007176.
21. Roberts H. 1981. Perspective on vitamin E as therapy. JAMA 246: 129-131.
22. Berry D, Wathen JK, Newell M. 2009. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin Trials 6: 28-41.
23. Biesalski HK, Grune T, Tinz J, Zollner I, Blumberg JB. 2010. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients 2: 929-949.
24. Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, McNeill G, Milne AC, Ramsay CR, Seymour DG, Stephen AI, Vale LD. 2005. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ 331: 324-329.
25. Girodon F, Lombard M, Galan P, Brunet-Lecomte P, Monget AL, Arnaud J, Preziosi P, Hercberg S. 1997. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 41: 98-107.
26. Girodon F, Galan P, Monget AL, Boutron-Ruault MC, Brunet-Lecomte P, Preziosi P, Arnaud J, Manuguerra JC, Herchberg S. 1999. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 159: 748-754.
27. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, Yu Y, Liu BQ, Tangrea J, Sun YH, Liu FS, Fraumeni JF, Zhang YH, Li B. 1993. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85: 1483-1492.
28. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, Hercberg S. 2004. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24: 1485-1491.
29. Heinonen OP, Albanes D. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330: 1029-1035.
30. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, Guo W, Liu SF, Yang CS, Shen Q, Wang W, Mark SD, Zou XN, Greenwald P, Wu YP, Blot WJ. 1993. Nutrition intervention trials in Linxian, China: multiple vitamin/ mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85: 1492-1498.
31. Liu BA, McGeer A, McArthur MA, Simor AE, Aghdassi E, Davis L, Allard JP. 2007. Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J Am Geriatr Soc 55: 35-42.
32. You WC, Chang YS, Heinrich J, Ma JL, Liu WD, Zhang L, Brown LM, Yang CS, Gail MH, Fraumeni JF Jr, Xu GW. 2001. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur J Cancer Prev 10: 257-263.
33. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH. 2004. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 292: 828-836.
34. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. 2008. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300: 2123-2133.
35. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. 2007. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 167: 1610-1618.
36. de Gaetano G. 2001. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357: 89-95.
37. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
38. Bairati I, Meyer F, Jobin E, Gelinas M, Fortin A, Nabid A, Brochet F, Tetu B. 2006. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 119: 2221-2224.
39. Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S. 2005. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 112: 1339-1346.
40. Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP. 2008. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol 28: 341-347.
41. Group A-REDSR. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119: 1439-1452.
42. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786.
43. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301: 39-51.
44. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. 2002. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288: 2432-2440.
45. Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD, Haile RW, Mandel JS, Nierenberg DW, Rothstein R, Snover DC, Stevens MM, Summers RW, van Stolk RU. 1994. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331: 141-147.
46. McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. 2004. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 111: 75-84.
47. Magliano D, McNeil J, Branley P, Shiel L, Demos L, Wolfe R, Kotsopoulos D, McGrath B. 2006. The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers. Eur J Cardiovasc Prev Rehabil 13: 341-347.
48. Desnuelle C, Dib M, Garrel C, Favier A. 2001. A doubleblind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord 2: 9-18.
49. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. 2005. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47-55.
50. Group HPS. 2002. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 highrisk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33.
51. Chylack LT Jr, Brown NP, Bron A, Hurst M, Kopcke W, Thien U, Schalch W. 2002. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 9: 49-80.
52. Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sanchez V, Garcia R, Buiatti E, Aebischer C, Franceschi S, Oliver W, Munoz N. 2007. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a random ized trial in a high-risk population. J Natl Cancer Inst 99: 137-146.
53. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. 2000. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218.
54. Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ. 1996. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 10: 132-140.
55. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336: 1216-1222.
56. Shoulson I, Oakes D, Fahn S, Lang A, Langston J, LeWitt P, Olanow C, Penney J, Tanner C, Kieburtz K. 1998. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Ann Neurol 43: 318-325.
57. Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph A, Becker G, Osterhage J. 2005. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 112: 649-660.
58. Thomas SR, Neuzil J, Stocker R. 1996. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol 16: 687-696.
59. Eder K, Flader D, Hirche F, Brandsch C. 2002. Excess dietary vitamin E lowers the activities of antioxidative enzymes in erythrocytes of rats fed salmon oil. J Nutr 132: 3400-3404.
60. Roberts HJ. 1978. Vitamin E and thrombophlebitis. Lancet 1: 49.
61. Murphy BF. 1974. Letter: Hypervitaminosis E. JAMA 227: 1381.
62. Roberts HJ. 1981. Perspective on vitamin E as therapy. JAMA 246: 129-131.
63. Saltzman RL, Peterson PK. 1987. Immunodeficiency of the elderly. Rev Infect Dis 9: 1127-1139.
64. Lang S, Lauffer L, Clausen C, Lohr I, Schmitt B, Holzel D, Wollenberg B, Gires O, Kastenbauer E, Zeidler R. 2003. Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J 17: 286-288.
65. Erf GF, Bottje WG, Bersi TK, Headrick MD, Fritts CA. 1998. Effects of dietary vitamin E on the immune system in broilers: altered proportions of CD4 T cells in the thymus and spleen. Poult Sci 77: 529-537.
66. Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, Colditz GA, Rosner B, Spiegelman D, Willett WC. 2004. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96: 1577-1584.
67. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, Buring JE. 1995. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5: 255-260.